top-header

menu

news

News dal mondo

21

Mag

Will established generics firms take Trump's cue and bring drug manufacturing to the U.S.?

The COVID-19 pandemic is reshaping the global supply chain, and the Trump administration has a message for established generics drugmakers: Bring your manufacturing on shore, or we will find new companies that do...[FiercePharma]

03

Lug

Generici e biosimilari. Presentato alle Istituzioni il “Manifesto per la ripartenza”

Una nuova politica industriale che garantisca sostenibilità al comparto pharma, assicurando a tutte le sue componenti regole chiare, certe e semplificate e ridia maggiore autonomia e capacità...

30

Giu

The COVID-19 Pandemic Sheds Light on the Over-Reliance on Offshore Drug Manufacturers

Four ideas to bring drug substance and drug product manufacturing back to the U.S....[ContractPharma]

30

Giu

Active Pharmaceutical Ingredients: How dependent is India on China

Despite calls to reduce imports from China, India's reliance on its hostile neighbour for the pharmaceutical sector remains. At least 60% of India's Active Pharmaceutical Ingredient (API) requirements...

26

Giu

EMA nominates executive director to replace Rasi

The European Medicines Agency’s (EMA) Management Board on Thursday nominated Emer Cooke from a short list of candidates to succeed Guido Rasi as the agency’s next executive director...[EMA]

slider-banner

home-footer
pager